Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya
A latent class analysis signaling needs for innovation in service delivery
Dados Bibliográficos
| ID | 14907263 |
|---|---|
| Autores | Hannah N Manley (0009-0000-5613-0275, Albert Einstein College of Medicine), Lindsey R Riback (0000-0001-8805-270X, Albert Einstein College of Medicine), Chenshu Zhang (0000-0002-3233-3905, Albert Einstein College of Medicine), Peter Vickerman (0000-0002-8291-5890, University of Bristol), Jack Stone (0000-0002-4584-0068, University of Bristol), John Geoffrey Walker (0000-0002-9732-5738, University of Bristol), Josephine G Walker, Mercy Nyakowa (Ministry of Health), Rose Wafula (0009-0006-4379-9598, Ministry of Health), Nazila Ganatra (0000-0003-1685-8979, Ministry of Health), Matthew J Akiyama (0000-0003-4290-3083, Albert Einstein College of Medicine, autor correspondente) |
| Ano | 2025 |
| Volume | 145 |
| Páginas | 105012 |
| Data de publicação | 2025-11-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | International Journal of Drug Policy (JOURNAL) |
| Identificadores do periódico | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2025.105012 |
| PMID | 40961832 |
| OpenAlex | W4414223070 |
| Idioma | EN |
| Referências citadas | 51 |
Differential (mechanical device · Hepatitis C · Hepatitis C virus · Human immunodeficiency virus (HIV · Latent class model · Psychological intervention · Service (business · Service delivery framework · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs
HIV, HCV, and Health-Related Harms Among Women Who Inject Drugs
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs
The importance of social networks in their association to drug equipment sharing among injection drug users
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs
Practitioner’s Guide to Latent Class Analysis
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs
Maximum Likelihood from Incomplete Data Via the EM Algorithm
Latent Risk Subtypes Based on Injection and Sexual Behavior Among People Who Inject Drugs in Rural Puerto Rico
The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users
Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection
Fire in the vein
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya
Harm reduction for young people who use prescription opioids extra-medically
Drug use typology, demographic covariates, and associations with condomless anal sex
Changes in hepatitis C virus prevalence and incidence among people who inject drugs in the direct acting antiviral era
Characteristics and risk of incarceration among “hard-to-reach” people who use drugs
Patterns of HIV Risks and Related Factors among People Who Inject Drugs in Kermanshah, Iran
Characterizing Drug use Typologies and Their Association with Sexual Risk Behaviors
Identifying Heterogeneity Among Injection Drug Users
Patterns of Chemsex Substance Use and Its Association with HIV Transmission Risk Among Men Who Have Sex with Men in Thailand
| Velocidade de citação | historical |
|---|---|
| Altamente citado | Não |